1. The introduction of new technology, surgeon and patient awareness and the growing demand for minimally invasive procedures are having the biggest impact on the spinal fusion market.
2. The demineralized bone matrix segment had the largest market share in 2014 and was bigger than the bone morphogenetic proteins, synthetic bone graft extenders and stem cell therapy.
3. The BMP segment is expected to be the fastest-growing segment because of the increasing demand for minimally invasive interventions and short procedure turnaround times.
4. Stem cell therapy and visco supplements will change the scenario in the global spinal fusion bone graft substitute market over the next few years.
5. The synthetic material segment is anticipated to have lucrative growth over the next seven years.
6. There is an increasing penetration of ceramics and composite triggered the demand for synthetic material.
7. North America has the largest spinal fusion bone graft substitutes market and is expected to grow over the next few years.
8. The excellent healthcare infrastructure and growing research and development initiatives are expected to drive North America’s growth.
9. The Asia Pacific segment is expected to have lucrative growth over the next few years.
10. The increased aging population, more spinal bone graft surgeries, improving disposable income and increased awareness of substitutes in developing economies will drive growth in the Asia Pacific market.
More articles on spine surgery:
Spinal cord injuries rising among the elderly—5 facts to note
Tidelands Health names Dr. T. Scott Ellison to board of trustees
Spine surgery’s RTCs are fragile
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.